Increase in incidences of road accidents, surge in geriatric population, rise in medical tourism and ambulatory surgical clinics, and growing number of surgical operations drive the growth of the global hospital beds market. Based on technology, the powered beds segment contributed to the major share in 2021. By region, on the other hand, Asia-Pacific would remain lucrative throughout the forecast period.
Portland, OR, Aug. 07, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Hospital Beds Market was estimated at $3.39 billion in 2021 and is expected to hit $7.15 billion by 2031, registering a CAGR of 7.4% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market. The report is exclusively meant to help the readers with a comprehensive valuation of industry analysis and trends.
Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/15743
No. of Pages in Report
End User, Technology, Application, and Region.
Increase in incidences of road accidents and surge in the geriatric population, rise in medical tourism and ambulatory surgical clinics and growing number of surgical operations
Advancements in hospital beds, product launches, and product approvals
The majority of countries, during the period, created isolation centers with healthcare facilities which propelled the expansion of hospital beds market.
For critically ill patients, advanced hospital beds are found useful with features such as wheels, elevation, CPR function, and nurse call system. This factor had a sheer positive impact on the market.
Moreover, the pandemic increases preference for home-based treatment which heightened the demand for hospital beds for home care too.
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/15743?reqfor=covid
The global market hospital beds market is analyzed across end user, technology, application, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Based on end user, the hospitals segment contributed to more than half of the global hospital beds market revenue in 2021, and is expected to lead the trail by the end of 2031. The same segment would also exhibit the fastest CAGR of 7.8% throughout the forecast period. The ambulatory surgical centers segment is also analyzed in the study.
Based on technology, the powered beds segment contributed to nearly three-fifths of the global hospital beds market revenue in 2021, and is expected to dominate by 2031. The same segment would also showcase the fastest CAGR of 7.8% throughout the forecast period. The manual beds segment is also assessed in the study.
Based on application, the long-term care segment nearly half of the total market revenue in 2021, and is expected to dominate by 2031. The acute care segment, simultaneously, would manifest the fastest CAGR of 8.1% throughout the forecast period.
Purchase Inquire: https://www.alliedmarketresearch.com/purchase-enquiry/15743
Based on region, the market across Asia-Pacific generated more than one-third of the total market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The same region would also showcase the fastest CAGR of 8.0% during the forecast period. The other regions studied in the report include North America, LAMEA, and Europe.
The key market players analyzed in the global hospital beds market report include Antano Group S.R.L., Baxter Corporation, Drive Medical, Getinge AB, Invacare Corporation, Linet SPOL S.R.O., Stiegelmeyer GMBH & Co and Stryker Corporation, Amico Corporation, Graham Field, Medline Industries Inc, Med-Mizer Inc, Midmark Corporation, Novum Medical Technology, Paramount Bed Holdings, Burke Bariatric Inc, and Savaria Corporation. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):
Biomaterials Market by Type (Metallic, Polymeric, Ceramic, and Natural) and Application, (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders, and Drug Delivery Systems): Global Opportunity Analysis and Industry Forecast, 2021–2030
Point of Care Diagnostics Market by Product (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy And Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs Abuse Testing Kits, Others), by Mode Of Prescription (Prescription Based Devices, Otc Based Devices), by End User (Professional Diagnostic Centers, Research Laboratories, Home Care, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
Surgical Microscopes Market by Application (Dentistry, Ent, Gynecology & Urology, Neurosurgery & Spine Surgery, Oncology, Ophthalmology, Plastic And Reconstructive Surgeries), by End-User (Hospitals, Outpatient Facilities), by Price Range (Low-Range, Mid-Range, Premium-Range): Global Opportunity Analysis and Industry Forecast, 2020-2030
Biosurgery Market by Product Type (Anti Adhesive Agents, Bone Graft Substitutes, Hemostatic And Surgical Sealant, Mesh), by Application (Cardiovascular And Thoracic Surgery, Neuro And Spine Surgery, Orthopedic Surgery, General Surgery), by Source (Biologics Products, Synthetic Products): Global Opportunity Analysis and Industry Forecast, 2020-2030
In Vitro Toxicity Testing Market by Type (Absorption, Toxic Substances, Dose), by Techniology (Cell Culture Technologies, High Throughput Technologies, Toxicogenomics), by End User (Cosmetics and Households Products, Pharmaceuticals Industry, Food Industry, Chemicals Industry): Global Opportunity Analysis and Industry Forecast, 2020-2030
Epigenetics Market by Product (Kits, Reagents, Enzymes, Instruments), by Application (Oncology, Non Oncology), by End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2020-2030
David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com/reports-store/life-sciences Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/
The big shareholder groups in Event Hospitality & Entertainment Limited ( ASX:EVT ) have power over the company. Large...
The US Senate has passed a landmark tax, climate and health-care bill, speeding a slimmed-down version of President Joe Biden's domestic agenda. The House is expected to pass the bill on Friday. Wendy Benjaminson reports on Bloomberg Television.
Every investor in New Century Resources Limited ( ASX:NCZ ) should be aware of the most powerful shareholder groups...
How far off is United Overseas Australia Limited ( ASX:UOS ) from its intrinsic value? Using the most recent financial...
Domain Holdings Australia (ASX:DHG) has had a great run on the share market with its stock up by a significant 14% over...
(Bloomberg) -- Colombia’s first leftist president was sworn in to start his four-year term on Sunday, pledging to redistribute wealth and re-think the “failed” war on drugs. Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillUS Inflation Peak in Sight But Debate Ra
(Bloomberg) -- More Asian governments are putting prices on emissions to try and curb global warming, but the region’s carbon markets and taxes are mostly off to slow and disappointing starts. Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillUS Inflation Peak in
The super investor still sees opportunities ahead.
After July’s exceptional surge, the markets steadied during early August with the S&P 500 up by a third of a precent over the past week. Now investors will be keen to find out if the rally has legs. Stifel's chief equity strategist Barry Bannister thinks it does and believes the S&P 500 is on course to reach 4,400 during the year’s second half, explaining that the sell-off in 1H22 is “still being reversed.” The strategist also thinks the S&P 500’s “equity risk premium” now suggests a mid-point p
(Bloomberg) -- Warren Buffett’s Berkshire Hathaway Inc. is following an age-old adage: Buy the dip.Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillUS Inflation Peak in Sight But Debate Rages Over What Comes NextThe conglomerate was a net buyer of equities in the
Berkshire Hathaway Inc said on Saturday that Vice Chairman Greg Abel, who is next in line to succeed billionaire Warren Buffett as chief executive, sold his 1% stake in the company's Berkshire Hathaway Energy unit for $870 million. In its quarterly report, Berkshire said the energy unit bought out Abel in June under an agreement among them and the family of the late billionaire philanthropist Walter Scott, which owns an 8% stake. Buffett's Omaha, Nebraska-based conglomerate took a $362 million charge to capital, reflecting the premium over how much the stake's value was reflected on its books.
(Bloomberg) -- President Joe Biden and Senate Majority Leader Chuck Schumer are the biggest winners now that a huge piece of Democrats’ economic agenda is hurtling toward enactment. Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillUS Inflation Peak in Sight But D
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Garmin Ltd. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.
Once the mightiest of industrial conglomerates, GE is breaking into three pieces. It's time to value each of the businesses.
Since touching their respective closing highs between mid-November and the first week of January, the iconic Dow Jones Industrial Average, widely tracked S&P 500, and growth-dependent Nasdaq Composite have plunged as much as 19%, 24%, and 34%. While the Dow came within a bad day of ending in bear market territory, the S&P 500 and Nasdaq were firmly entrenched there. If there's a silver lining to the worst first-half to a year for the S&P 500 since 1970, it's that bargains abound for patient investors.
The Apple (AAPL) empire might be spearheaded by its flagship product, the iPhone, but along with plenty of other hardware offerings, its Services segment has been growing at a fast pace. There’s also talk of a “game changing” AV/VR headset and even of an Apple Car at some point. But Needham analyst Laura Martin thinks there’s also the prospect of another big revenue stream. “We believe AAPL is in the early stages of building a new mobile advertising platform,” says Martin, who thinks ad revenue
The focus on China's actions toward Taiwan puts the spotlight on the chip industry, and these are stocks to keep on the radar for possible volatility.
A recession? Don’t tell that to the stock market. The major averages ended positive for the week. That came after the best month for the S&P 500 since November 2020.
Bank of America Corporation ( NYSE:BAC ) has announced that it will be increasing its dividend from last year's...
(Bloomberg) -- The ugliest year ever for US corporate-bond investors is expected to get uglier -- and they only have the Federal Reserve to blame.Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillUS Inflation Peak in Sight But Debate Rages Over What Comes NextWith